Sfoglia per SSD
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists
2018 Facchini, F; Zaffaroni, L; Minotti, A; Rapisarda, S; Calabrese, V; Forcella, M; Fusi, P; Airoldi, C; Ciaramelli, C; Billod, J; Schromm, A; Braun, H; Palmer, C; Beyaert, R; Lapenta, F; Jerala, R; Pirianov, G; Martin-Santamaria, S; Peri, F
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108
2018 Pallach, M; Di Lorenzo, F; Facchini, F; Gully, D; Giraud, E; Peri, F; Duda, K; Molinaro, A; Silipo, A
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
2017 Perrin Cocon, L; Aublin Gex, A; Sestito, S; Shirey, K; Patel, M; André, P; Blanco, J; Vogel, S; Peri, F; Lotteau, V
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis
2017 Kuzmich, N; Sivak, K; Chubarev, V; Porozov, Y; Savateeva-Lyubimova, T; Peri, F
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling
2017 Cochet, F; Peri, F
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling
2017 Sestito, S; Facchini, F; Morbioli, I; Billod, J; Martin Santamaria, S; Casnati, A; Sansone, F; Peri, F
The EuroSciCon's 2015 Innate Immunity Summit
2016 Camprubí Rimblas, M; Peri, F; Mcknight, Á; Matteucci, C; Guillamat Prats, R
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model
2016 De Paola, M; Sestito, S; Mariani, A; Memo, C; Fanelli, R; Freschi, M; Bendotti, C; Calabrese, V; Peri, F
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development
2015 Huggins, C; Pearce, S; Peri, F; Neumann, F; Cockerill, G; Pirianov, G
Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles
2015 Calabrese, V; Cighetti, R; Peri, F
Chemistry of lipid a: At the heart of innate immunity
2015 Molinaro, A; Holst, O; Lorenzo, F; Callaghan, M; Nurisso, A; D'Errico, G; Zamyatina, A; Peri, F; Berisio, R; Jerala, R; Jiménez Barbero, J; Silipo, A; Martín Santamarí, S
Design, synthesis and biological characterization of new small-molecule TLR4 modulators
2014 Cighetti, R
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity
2012 Peri, F; Piazza, M; Cighetti, R; Damore, G; Calabrese, V; Weiss, J; Gioannini, T
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets
2011 Piazza, M; Damore, G; Costa, B; Gioannini, T; Weiss, J; Peri, F
Modulation of LPS signaling through TLR4 agonists and antagonists
2011 Peri, F; Cighetti, R; Piazza, M; Calabrese, V
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding
2010 Piazza, M; Calabrese, V; Baruffa, C; Gioannini, T; Weiss, J; Peri, F
Exploring the LPS/TLR4 signal pathway with small molecules
2010 Peri, F; Piazza, M; Calabrese, V; Damore, G; Cighetti, R
A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: combining conventional synthesis and microwave-assistance
2008 Melato, S; Prosperi, D; Coghi, P; Basilico, N; Monti, D
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor
2007 Stabile, H; Mitola, S; Moroni, E; Belleri, M; Nicoli, S; Coltrini, D; Peri, F; Pessi, A; Orsatti, L; Talamo, F; Castronovo, V; Waltregny, D; Cotelli, F; Ribatti, D; Marco, P
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity
2006 Peri, F; Nicotra, F; Granucci, F; Costa, B
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile